Stoke Therapeutics Shares Are Trading Lower After the Company Announced the Pricing of an Upsized $125 Million Public Offering of 5,555,557 Common Shares at $13.50 per Share
Stoke Therapeutics宣佈將5,555,557股普通股的1.25億美元公開發行定價爲每股13.50美元，此後，Stoke Therapeutics的股價走低